Because, one, the reviews are not disclosed publicly; and two, some of the researchers have actually told us that they would prefer to remain anonymous because they would be subject to lobbying.
On June 6th, 2007. See this statement in context.
On June 6th, 2007. See this statement in context.
June 6th, 2007 / 4:20 p.m.
Vice-President, Common Drug Review, Canadian Agency for Drugs and Technologies in Health
Because, one, the reviews are not disclosed publicly; and two, some of the researchers have actually told us that they would prefer to remain anonymous because they would be subject to lobbying.
See context to find out what was said next.